ArticleCancers2025

ROR1 as an Immunotherapeutic Target for Inducing Antitumor Helper T Cell Responses Against Head and Neck Squamous Cell Carcinoma.

Ryosuke Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.